Oppenheimer & Co’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-666	Closed	-$24.6K	–	1391
2023 Q3	$24.6K	Sell	666 -237	-26%	-$10.5K	﹤0.01%	1362
2023 Q2	$36.3K	Sell	903 -149	-14%	-$8.43K	﹤0.01%	1391
2023 Q1	$76.3K	Sell	1,052 -42	-4%	-$4.07K	﹤0.01%	1334
2022 Q4	$89.7K	Sell	1,094 -119	-10%	-$12.4K	﹤0.01%	1297
2022 Q3	$115K	Sell	1,213 -162	-12%	-$18.2K	﹤0.01%	1289
2022 Q2	$268K	Sell	1,375 -66	-5%	-$10.8K	0.01%	1147
2022 Q1	$335K	Buy	1,441 +37	+3%	+$11.8K	0.01%	1152
2021 Q4	$553K	Buy	1,404 +6	+0.4%	+$2.53K	0.01%	997
2021 Q3	$625K	Buy	1,398 +624	+81%	+$224K	0.01%	925
2021 Q2	$301K	Buy	774 +23	+3%	+$8.2K	0.01%	1238
2021 Q1	$270K	Buy	751 +25	+3%	+$11.1K	0.01%	1225
2020 Q4	$356K	Buy	726 +43	+6%	+$19.8K	0.01%	1030
2020 Q3	$221K	Buy	+683	New	+$233K	0.01%	1118
2019 Q4	–	Sell	-507	Closed	-$179K	–	1275
2019 Q3	$179K	Buy	507 +102	+25%	+$38.1K	﹤0.01%	1162
2019 Q2	$203K	Buy	405 +53	+15%	+$37.4K	0.01%	1183
2019 Q1	$350K	Buy	352 +50	+17%	+$46.5K	0.01%	966
2018 Q4	$262K	Sell	302 -2	-0.7%	-$1.86K	0.01%	1000
2018 Q3	$315K	Hold	304	–	–	0.01%	1047
2018 Q2	$280K	Buy	+304	New	+$327K	0.01%	1085